Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Improving Return-to-Work Outcomes in Australia
Total 0 results
Nothing found
Sponsors and Collaborators
ATTRaCT program by A*STAR BMRC Singapore
Kyongtae Ty Bae, M.D., Ph.D.
Zhengzhou First People's Hospital
Menzis
Brandeis University
Intermed Hospital
Jennifer King
Klinikum Freising
Creighton University
Seed Health
Chengdu Integrated TCM&Western Medicine Hospital
CEVAC Core Lab, University Ghent
Sysmex Inostics GmbH
R.Bos
metaMe Health
Chul Kim
African Institute for Health and Development
Meyer Children's Hospital, Florence, Italy
French National Society of Gastroenterology
Bioraba
View Full List
Medical Conditions
Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+)
Bacterial Reduction Post-product Application
Regenerative Periodontal Treatment
Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
Root Canal Sealers
Alert Fatigue, Health Personnel
Mild Traumatic Brain Injury; Concussion
Systemic Lupus Erythematosus Nephritis
Parenteral Iron Therapy
Chronic Hepatitis C Virus Infection
Early Phase of Severe Sepsis and Septic Shock
Bleeding at Gastric Cancer
Value-Based Health Insurance
Cell Phone Use
Burn Wound and Skin Graft Healing
Failure; Cardiac
Adductor Pollicis
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma
Plaque Type Psoriasis
Hearing Loss, Bilateral or Unilateral
View Full List
Drug Interventions
IDP-126 Vehicle Gel
Galantamine CR
Methylphenidate
Itraconazole
Phase 2a, SQY51 (cohort 3)
PF-06650833
Fesoterodine
Leucovorin
Bupivacaine 0.5%
Follitropin beta liquid formulation
Insulin glargine
30 mg CVL-231 Target Release, Fed
LFG316 active drug
Estradiol plus MPA
Soy protein isolate
0.27 mg/kg, age≥65
Ciclesonide
Nitric Oxide gas at 160ppm
Stem Cell Product
Esketamine
View Full List
CROs by country
Contract Research Organizations in Cyprus
Contract Research Organizations in Ethiopia
Contract Research Organizations in Germany
Contract Research Organizations in Guatemala
Contract Research Organizations in Jordan
Contract Research Organizations in Kenya
Contract Research Organizations in Lebanon
Contract Research Organizations in Mozambique
Contract Research Organizations in Paraguay
Contract Research Organizations in Qatar
Contract Research Organizations in Romania
Contract Research Organizations in Togo
Contract Research Organizations in United Kingdom
CRO list by country
CROs in Lebanon
Syneos Health
SGS
ClinServ
MCT
ACROSS Global
All CROs in Lebanon
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe